期刊文献+

肺结节与肺癌全程智能管理云平台的构建及临床应用 被引量:6

Construction and clinical application of cloud platform for intelligent management of lung nodules and lung cancer
原文传递
导出
摘要 目的我国肺癌患病率、病死率稳居恶性肿瘤第一位。创建肺结节与肺癌全程管理模式,将肺结节纳入规范诊疗体系,以期实现肺癌早诊早治,提高患者复诊依从性。方法构建肺结节与肺癌全程智能管理云平台,建立恶性肺结节队列、良性肺结节队列和未确诊肺结节规律随访队列。收集人口统计学、影像、病理、疗效等信息,通过全程管理后分析人群特征、诊治精准性与复诊率。结果创建了基于重庆市肺结节管理工作室的肺结节与肺癌全程智能管理云平台。2019年1月至2021年12月期间,纳入全程管理的肺结节与肺癌患者共5144例,确诊肺结节1546例(30.05%),其中恶性1194例,良性352例;Ia期肺癌占确诊肺癌的(80.80%);随访中肺结节3598例(69.95%)。2019年进入平台登记管理后未确诊的肺结节,有≥1次复诊记录的患者652例(74.86%);2020年667例(65.67%);2021年245例(13.94%)。结论建立肺结节与肺癌全程智能管理云平台有利于提高恶性肺结节早诊早治率与患者依从性,促进患者自我健康管理模式养成,改善肺癌预后,值得尝试。 Objective Lung cancer is the most common cause of death with malignant tumor in China.The whole-process management mode of lung nodules and lung cancer was established,and lung nodules were included in the standardized diagnosis and treatment system,aim to improve the rate of early diagnosis and treatment for lung cancer,compliance of patients with following up.Methods A cloud platform for the whole-process intelligent management of pulmonary nodules and lung cancer was constructed.Malignant pulmonary nodules,benign pulmonary nodules and undiagnosed pulmonary nodules queues were established.Demographic,imaging,pathological,curative effect and other information were collected,and population characteristics,diagnosis and treatment accuracy and return visit rate were analyzed after the whole process of management.Results A cloud platform for whole-process intelligent management of pulmonary nodules and lung cancer was established based on Chongqing Pulmonary Nodules Management Studio.From January 2019 to December 2021,a total of 5144 patients with pulmonary nodules and lung cancer were included in the whole-course management.1546 patients(30.05%)were confirmed including 1194 malignant cases and 352 benign cases.Lung cancer with Stage Ia was accounted for 80.80%.3598 patients(69.95%)with lung nodules in follow up.Among undiagnosed pulmonary nodules after entering the platform registration management in 2019,the proportion of patients with≥1 following-up was 74.86%.667 patients(65.67%)in 2020.245 patients(13.94%)in 2021.Conclusion The establishment of the cloud platform for the whole-process intelligent management of pulmonary nodules and lung cancer is beneficial to improve the rate of early diagnosis and treatment of malignant pulmonary nodules and patient compliance,promote the development of self-health management mode of patients and the prognosis of lung cancer,which is worthy of further promotion.
作者 杨丽 王婷 敖敏 李维益 刘迅 秦明 郭述良 Yang Li;Wang Ting;Ao Min;Li Weiyi;Liu Xun;Qin Ming;Guo Shuliang(Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China;Breathfree (Chongqing) Technology Company, Chongqing 400000, China)
出处 《中华肺部疾病杂志(电子版)》 2022年第1期11-14,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 重庆市科学技术局技术创新与应用发展专项面上项目(cstc2019jscx-msxmX0184) 人工智能辅助肺结节诊治一体化全程管理数据平台的建设与应用(项目负责人杨丽) 重庆医科大学附属第一医院学科创新基金学科培育项目(XKST134) 肺结节与肺癌大数据全程智能管理云平台(项目负责人杨丽)。
关键词 肺结节 支气管肺癌 人工智能 全程管理 数据云平台 Pulmonary nodules Bronchogenic carcinoma Intelligent Comprehensive management Data Cloud Platform
  • 相关文献

参考文献2

二级参考文献31

  • 1Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China:l. Retrospective proportional mortality study of one million deaths[J]. BMJ,1998, 317(7170) : 1411-1422.
  • 2She J, Yang P, Hong Q, et al. Lung cancer in china: challenges and interventions[J]. Chest, 2013, 143(4) : 1117-1126.
  • 3vanKlaveren R J, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning[ J]. N Engl J Med, 2009, 361 (23): 2221-2229.
  • 4National Lung Screening Trial Research Team, Aberle DR, BergCD, et al. The national lung screening triM: overview and study design J]. Radiology,2011,258 : 243-253.
  • 5Aberle DR, Adams AM, Berg CD, et al. Reduced lung cancer mortality with low-dose computed tomographic screening [ J ]. N Engl J Med,2011,365(5) : 395-409.
  • 6Gould MK, Ananth L, Barnett PG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[ J]. Chest, 2007,131 (2) : 383-388.
  • 7Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and Management of Lung Cancer. 3rd ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2013, 143(5 Suppl) : e93S-e120S.
  • 8Ost D, Fein A. Management strategies for the solitary pulmonary nodule[ J]. Curr Opin Pulm Med,2004,10(4) : 272-278.
  • 9Zhang J, Cui LB, Tang X, et al. DW MRI at 3.0-T versus FDG PET/CT for detection of malignant pulmonary tumors [ J ] Int J Cancer,2014,134 ( 3 ) :606-611.
  • 10Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning [ J ]. Thorax,201 l, 66 (4) : 315-319.

共引文献186

同被引文献70

引证文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部